中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共30条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer 期刊论文
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 卷号: 14
作者:  Yan, Min;  Yuan, Peng;  Ouyang, Quchang;  Cheng, Ying;  Han, Guohui;  Wang, Dewei;  Ran, Li;  Sun, Tao;  Zhao, Da;  Bai, Yuju;  Yang, Shun'e;  Wang, Xiaojia;  Wu, Rong;  Zeng, Xiaohua;  Yao, Herui;  Ji, Xuening;  Jiang, Jun;  Hu, Xiaohua;  Lin, Haifeng;  Zheng, Liping;  Zhu, Zhitu;  Ge, Wei;  Yang, Junlan;  Cui, Tongjian;  Zhang, Xiaozhi;  Lu, Fangyang;  Li, Wenhui;  Xu, Hongyan;  Kang, Mafei;  Gong, Ping;  Zou, Liqun;  Liu, Jiang;  Zhang, Hongliang;  Yu, Hao;  Xu, Binghe
收藏  |  浏览/下载：52/0  |  提交时间：2022/12/23
breast cancer  chemotherapy  efficacy  lobaplatin  neoplasm metastasis  safety  
Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:  Wu, Xiaofan;  Yang, Hongjian;  Yu, Xingfei;  Qin, Jiang-Jiang
收藏  |  浏览/下载：50/0  |  提交时间：2022/12/22
HER2  breast cancer  targeted therapy  drug resistance  overcoming strategies  
Platelet-to-Lymphocyte ratio (PLR) as a predictive marker in HER2 positive metastatic breast cancer patients treated with first-line trastuzumab therapy. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Fang, Zi-Ru;  Shen, Xia-Bo;  Wu, Jia-Yi;  Chen, Ke-Yu;  Shao, Xi-Ying;  Wang, Xiaojia
收藏  |  浏览/下载：45/0  |  提交时间：2022/12/23
Label-Free Detection and Translocation Dynamics Study of Single-Molecule Herceptin Using Solid-State Nanopores 期刊论文
ADVANCED MATERIALS TECHNOLOGIES, 2022
作者:  Hu, Rui;  Lu, Wenlong;  Wei, Guanghao;  Nan, Hexin;  Li, Juan;  Zhao, Qing
收藏  |  浏览/下载：37/0  |  提交时间：2022/12/23
solid-state nanopore  single-molecule detection  protein dynamics  monoclonal antibody  protein unfolding  
Efficacy of everolimus-containing chemotherapy in HER2 negative metastatic breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Wang, Rong;  Wang, Xiaojia;  Chen, Zhan-Hong;  Niu, Jin;  Huang, Yuan;  Pan, Jiani;  Ye, Weiwu;  Cao, Wenming
收藏  |  浏览/下载：64/0  |  提交时间：2022/01/10
Pyrotinib plus capecitabine for HER2-positive metastatic breast cancer patients with brain metastases (PERMEATE): A multicenter, single-arm phase II study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Yan, Min;  Ouyang, Quchang;  Sun, Tao;  Niu, Limin;  Yang, Jin;  Li, Li;  Song, Yuhua;  Hao, Chunfang;  Chen, Zhanhong
收藏  |  浏览/下载：39/0  |  提交时间：2022/01/10
Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Shao, Xiying;  Zheng, Yabing;  Cao, Wenming;  Shen, Xiabo;  Li, Guangliang;  Chen, Junqing;  Huang, Yuan;  Huang, Ping;  Shi, Lei;  Ye, Weiwu;  Zou, Weibin;  Lou, Caijin;  Lei, Lei;  Huang, Jian;  Chen, Zhanhong;  Wang, Xiaojia
收藏  |  浏览/下载：47/0  |  提交时间：2021/06/15
Ki67  progesterone receptor  palbociclib  
Exploring the concepts and practices of advanced breast cancer treatment: a narrative review 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:  Wang, Xiaojia;  Shao, Xiying;  Huang, Jian;  Lei, Lei;  Huang, Yuan;  Zheng, Yabing;  Cao, Wenming;  Chen, Zhanhong
收藏  |  浏览/下载：49/0  |  提交时间：2021/06/15
Metastatic breast cancer (MBC)  treatment  cure  molecular types  targeted therapy  
Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2-Breast Cancer Patient With High Tumor Mutational Burden 期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 10
作者:  Wang, Rong;  Yang, Yuchen;  Ye, Wei-Wu;  Xiang, Jianxing;  Chen, Songan;  Zou, Wei-Bin;  Wang, Xiao-Jia;  Chen, Tianhui;  Cao, Wen-Ming
收藏  |  浏览/下载：52/0  |  提交时间：2021/04/26
breast cancer  immunotherapy  biomarker  TMB  NGS  molecular monitoring  
Primary analysis of OVERSTEP: A multicenter, randomized clinical trial of capecitabine or endocrine therapy as a maintenance therapy after the 1st-line chemotherapy in hormone receptor positive and HER2-negative advanced/metastatic breast cancer 期刊论文
CANCER RESEARCH, 2021, 卷号: 81
作者:  Huang, Jian;  Shao, Xiying;  Cai, Li;  Shi, Yanxia;  Chen, Zhanhong;  Huang, Ping;  Yin, Yongmei;  Zhang, Lili;  Shen, Peng;  Cao, Wenming;  Ye, Weiwu;  Huang, Yuan;  Lou, Caijin;  Lei, Lei;  Zheng, Yabin;  Zou, Weibin;  Chen, Junqing;  Wang, Xiaojia
收藏  |  浏览/下载：47/0  |  提交时间：2021/04/26